文献速递眼底病与葡萄膜炎

增生性玻璃体视网膜病变初次手术失败后重复经平坦部玻璃体切除术的结局

OUTCOMES OF REPEAT PARS PLANA VITRECTOMY AFTER FAILED SURGERY FOR PROLIFERATIVE VITREORETINOPATHY.
PubMed 文献 · Retina · 2018-01-01

回顾性病例系列纳入2000至2015年Kresge眼科研究所51眼(50例)因增生性玻璃体视网膜病变初次玻璃体切除失败后行重复手术者,末次随访43眼(84.3%)视网膜复位,按视网膜复位、硅油取出且最佳矫正视力≥5/200的标准17眼(33.3%)成功、34眼(66.7%)未成功;失败组术前最佳矫正视力<5/200、手动或更差、房闪≥2+、后部裂孔、既往视网膜切除及末次随访低眼压者更多, logistic回归中距Detroit>100英里及术前视力手动或更差与失败显著相关。

要点

  • 末次随访43眼(84.3%)视网膜复位,按复合标准17眼(33.3%)成功、34眼(66.7%)未成功。
  • 失败组更多眼有术前最佳矫正视力<5/200(P<0.001)、手动或更差(P=0.002)、房闪≥2+(P=0.03)、后部裂孔(P=0.02)、既往视网膜切除(P=0.04)及末次低眼压≤5 mmHg(P=0.005)。
  • 硅油取出眼更可能末次最佳矫正视力≥5/200(P<0.001)。

核心结论

  • 重复手术治疗增生性玻璃体视网膜病变的成功应包含有用视力、视网膜复位和硅油取出。
  • 双变量和logistic分析发现若干术前与围手术期因素与成功相关。
  • 决定是否再次手术应基于多种因素,最重要的是术前最佳矫正视力。

研究设计与样本

  • 回顾性病例系列,纳入2000至2015年Kresge眼科研究所51眼(50例)因增生性玻璃体视网膜病变初次经平坦部玻璃体切除失败后行重复手术者。
  • 按视网膜复位、硅油取出且末次随访最佳矫正视力≥5/200定义为成功,分为成功组与未成功组。

主要发现

  • 末次随访43眼(84.3%)视网膜复位,17眼(33.3%)成功、34眼(66.7%)未成功。
  • 与成功组相比,未成功组术前最佳矫正视力<5/200眼更多(P<0.001)、术前最佳矫正视力手动或更差眼更多(P=0.002)、术前房闪≥2+眼更多(P=0.03)、术前后部裂孔眼更多(P=0.02)、既往视网膜切除眼更多(P=0.04)、末次术后低眼压(眼压≤5 mmHg)眼更多(P=0.005)。
  • 硅油取出眼末次随访最佳矫正视力≥5/200的可能性更高(P<0.001)。
  • logistic回归中,患者距Detroit>100英里(P=0.04)和术前最佳矫正视力手动或更差(P=0.01)与失败显著相关。

关键数值与推荐

  • 成功定义:视网膜复位、硅油取出且末次随访最佳矫正视力≥5/200,17眼(33.3%)符合。
  • 未成功34眼(66.7%)。
  • 末次随访视网膜复位43眼(84.3%)。

临床怎么用

  • 作者认为重复手术治疗增生性玻璃体视网膜病变的成功应包含有用视力、视网膜复位和硅油取出。
  • 作者认为决定是否再次手术应基于多种因素,最重要的是术前最佳矫正视力。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate outcomes of repeat pars plana vitrectomy for proliferative vitreoretinopathy after previous failed pars plana vitrectomy. METHODS: This is a retrospective case series including 51 eyes of 50 patients who underwent repeat surgery after failed previous pars plana vitrectomy for proliferative vitreoretinopathy from 2000 to 2015 at the Kresge Eye Institute, Detroit, MI. Patients were classified into successful and unsuccessful groups. Success was defined as retinal reattachment, silicone oil removed, and best-corrected visual acuity (BCVA) ≥5/200 at the final follow-up visit. RESULTS: Forty-three eyes (84.3%) were successfully reattached at the last follow-up. Seventeen (33.3%) eyes were deemed successful and 34 (66.7%) eyes unsuccessful according to our criteria. Compared with the successful group, eyes in the unsuccessful group had more eyes with preoperative BCVA <5/200 (P < 0.001), preoperative BCVA of hand motion or worse (P = 0.002), preoperative flare ≥Grade 2+ (P = 0.03), preoperative posterior breaks (P = 0.02), previous retinectomy (P = 0.04), and final postoperative hypotony (intraocular pressure ≤ 5 mmHg) (P = 0.005). Eyes with silicone oil removed were more likely to have BCVA ≥5/200 (P < 0.001) at the final follow-up visit. Location of patients >100 miles (P = 0.04) from Detroit and preoperative BCVA of hand motion or worse (P = 0.01) were significantly associated with failure in the logistic regression analysis. CONCLUSION: Success after repeat surgery for proliferative vitreoretinopathy should include ambulatory vision, retinal reattachment, and silicone oil removal. We identified several preoperative and perioperative factors that were associated with success in the bivariate and logistic analyses. The decision to perform surgical reoperation in these patients should be based on multiple factors, most importantly preoperative BCVA.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Narala R, Nassiri N, Kim C, et al. OUTCOMES OF REPEAT PARS PLANA VITRECTOMY AFTER FAILED SURGERY FOR PROLIFERATIVE VITREORETINOPATHY. Retina. 2018. PMID: 29232332. doi:10.1097/IAE.0000000000002000

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。